الإحصائيات الأساسية
| CIK | 1489161 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IMRIS Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| June 9, 2015 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the ? Company ?) 5101 Shady Oak Rd Minnetonka, Minnesota 55343 Item 2 Date of Material Change May 26, 2015 Item 3 News Release News release attached as Schedule ?A? was disseminated on May 26, 2015. Item 4 Summary of Material Change On May 25, 2015, the Company announced that the Company, its subsidiar |
|
| June 9, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| June 9, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| June 9, 2015 |
IMRIS Announces Receipt of Nasdaq Notice of Delisting Exhibit 99.1 IMRIS Announces Receipt of Nasdaq Notice of Delisting MINNEAPOLIS, June 1, 2015 /CNW/ - IMRIS Inc.(the Company)(NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter May 26, 2015 from the NASDAQ Stock Market LLC ("Nasdaq") stating that in accordance with Listing Rules 5101, 5110(b), and IM-5101-1, the Staff has determined that the Company's securities will be delis |
|
| May 26, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 26, 2015 |
EX-99.1 2 ex991.htm NEWS RELEASE DATED MAY 26, 2015 Exhibit 99.1 IMRIS Inc. and Two Subsidiaries File for Chapter 11 Protection Company Reaches Agreement With Deerfield Management Company, L.P. to Provide Debtor-In-Possession Financing and Purchase All Operating Businesses "Business as Usual" Operations to Continue During Chapter 11 MINNETONKA, MN, May 26, 2015 /CNW/ - IMRIS Inc. ("IMRIS" or "the |
|
| May 21, 2015 |
IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company Exhibit 99.2 IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company MINNEAPOLIS, MN, May 19, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today announced that Mike Fritts, Executive Vice President, Global Customer Service, and Mark Reade, Executive Vice President, Global Sales, have left the Company. Mr. Fritts departed effective May 15, 2015 and has serve |
|
| May 21, 2015 |
FORM 51-102F3 Material Change Report EX-99.1 2 ex991.htm MATERIAL CHANGE REPORT Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change May 15, 2015 Item 3 News Release News release attached as Schedule “A” was disseminated on May 19, 2015 via Canada NewsWire. Item 4 Summary of Material Cha |
|
| May 21, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address |
|
| May 8, 2015 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the ?Company?) 5101 Shady Oak Rd Minnetonka, Minnesota 55343 Item 2 Date of Material Change May 7, 2015 Item 3 News Release The news release attached as Schedule ?A? was disseminated on May 7, 2015, as a correction to the news release disseminated on May 6, 2015. This material change report has been re |
|
| May 8, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address |
|
| May 8, 2015 |
IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015 EX-99.2 3 ex992.htm NEWS RELEASE DATED MAY 7, 2015 Exhibit 99.2 IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015 MINNEAPOLIS, May 7, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") announces a correction to yesterday's press release which stated that the Company's shareholders of record on May 14, 2015 will be entitled to notice and to vote at the |
|
| May 7, 2015 |
Exhibit 99.2 IMRIS Announces Postponement of its Annual Meeting of Shareholders and Release of First Quarter 2015 Financial Results and Conference Call MINNEAPOLIS, May 6, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the Annual Meeting of Shareholders, which was scheduled for May 7th, 2015, has been rescheduled to June 25th, 2015. IMRIS also annou |
|
| May 7, 2015 |
Exhibit 99.1 Item 1 Name and Address of Company IMRIS Inc. (the ?Company?) 5101 Shady Oak Rd Minnetonka, Minnesota 55343 Item 2 Date of Material Change May 6, 2015 Item 3 News Release The news release attached as Schedule ?A? was disseminated on May 6, 2015. Item 4 Summary of Material Change On May 6, 2015, the Company announced that the Annual Meeting of Shareholders, which was scheduled for May |
|
| May 7, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address |
|
| April 23, 2015 |
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency Exhibit 99.2 IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency MINNEAPOLIS, April 22, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter, dated April 20, 2015, from the NASDAQ Stock Market LLC ("Nasdaq") stating that for the previous 30 consecutive business days the bid price of the Company's common stock closed below the minimum $1.00 |
|
| April 23, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Addre |
|
| April 23, 2015 |
FORM 51-102F3 Material Change Report EX-99.1 2 ex991.htm MCR Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change April 22, 2015 Item 3 News Release News release attached as Schedule “A” was disseminated on April 22, 20154 via Canada NewsWire. Item 4 Summary of Material Change ` IMRIS In |
|
| April 1, 2015 |
20-F 1 v39966220f.htm FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F o Registration Statement pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 or x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2014 or o Transition Report pursuant to Section 13 or 15(d) |
|
| March 30, 2015 |
EX-99.3 4 v405797ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 |
|
| March 30, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 30, 2015 |
EX-99.2 3 v405797ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 IMRIS Inc. NOTICE-AND-ACCESS NOTIFICAITON TO SHAREHOLDERS NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 7, 2015 NOTICE IS HEREBY GIVEN THAT the annual meeting of the shareholders of IMRIS Inc. (the “Corporation”) will be held on Thursday, May 7, 2015 at 11:00 a.m. (EST) at the DoubleTree Hilton Hotel Toronto, 108 Chestnut Street, T |
|
| March 30, 2015 |
Exhibit 99.1 IMRIS Inc. NOTICE-AND-ACCESS NOTIFICAITON TO SHAREHOLDERS NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 7, 2015 NOTICE IS HEREBY GIVEN THAT the annual meeting of the shareholders of IMRIS Inc. (the ?Corporation?) will be held on Thursday, May 7, 2015 at 11:00 a.m. (EST) at the DoubleTree Hilton Hotel Toronto, 108 Chestnut Street, Toronto Ontario, M5G 1R3, (the ?Meeting?), |
|
| March 26, 2015 |
VISIUS iCT provides highest quality OR imaging with low radiation dose management EX-99.1 2 ex991.htm NEWS RELEASE DATED MARCH 26, 2015 Exhibit 99.1 Health Canada greenlights IMRIS ceiling-mounted intraoperative CT solution VISIUS iCT provides highest quality OR imaging with low radiation dose management WINNIPEG, March 26, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that VISIUS® iCT, the first and only ceiling-mounted intraoperati |
|
| March 26, 2015 |
Imris FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 4, 2015 |
IMRIS Reports Fourth Quarter and Annual 2014 Financial Results Exhibit 99.1 IMRIS Reports Fourth Quarter and Annual 2014 Financial Results · New order bookings of $4.7 million in fourth quarter resulted in ending backlog of $116.4 million; · New order bookings totaled $51.4 million in 2014, up 55.8 percent versus $33 million in 2013; · Quarterly revenues of $9.6 million were near IMRIS' expectations, resulting in full-year revenues of $28.9 million; · Gross m |
|
| March 4, 2015 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| February 18, 2015 |
IMRIS Regains Compliance with NASDAQ Listing Requirements Exhibit 99.1 IMRIS Regains Compliance with NASDAQ Listing Requirements MINNEAPOLIS, MN, Feb. 17, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) IMRIS Inc. (the "Company" or "IMRIS") today announced that it has regained compliance with listing requirements of the NASDAQ Global Market. As previously reported, the Company received a letter, dated August 25, 2014, from the NASDAQ Stock Market LLC ("N |
|
| February 18, 2015 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2015 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| February 17, 2015 |
IMRSQ / Imris Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| February 13, 2015 |
IMRSQ / Imris Inc. / Graves H. David - FORM SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Amendment 4) UNDER THE SECURITIES EXCHANGE ACT OF 19341 IMRIS Inc. |
|
| February 9, 2015 |
IMRSQ / Imris Inc. / Whitecastle Investments Ltd - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) IMRIS INC. (Name of Issuer) COMMON SHARES (Title of Class of Securities) 45322N105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| January 12, 2015 |
IMRSQ / Imris Inc. / 1832 Asset Management L.P. - SCHEDULE 13G Passive Investment Imris Inc.: Schedule 13G - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Year End & Exit Filing)* IMRIS INC. (Name of Issuer) COMMON SHARES (Title of Class of Securities) 45322N105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| January 2, 2015 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 5101 Shady Oak Rd Minnetonka, Minnesota 55343 Item 2 Date of Material Change December 24, 2014 Item 3 News Release News releases attached as Schedule “A” and Schedule “B” were disseminated on December 22, 2014 and December 24, 2014, respectively. Item 4 Summary of Material Change On De |
|
| January 2, 2015 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| December 29, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| December 29, 2014 |
IMRIS Announces Closing of Private Placement Offering of Units Exhibit 99.1 IMRIS Announces Closing of Private Placement Offering of Units MINNEAPOLIS, Dec. 24, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced it has closed the private placement offering of 10,563,380 units at an offering price of US$0.284 per unit. Each unit (the "Units") consists of one common share of the Company (the "Common Shares") and one and a |
|
| December 23, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| December 23, 2014 |
IMRIS Announces Private Placement Offering of Units and Other Corporate Developments EX-99.1 2 ex991.htm NEWS RELEASE DATED DECEMBER 22, 2014 Exhibit 99.1 IMRIS Announces Private Placement Offering of Units and Other Corporate Developments MINNEAPOLIS, MN, Dec. 22, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced a private placement offering of 10,563,380 units at an offering price of US$0.284 per unit (the "Offering"). Each unit (the "Uni |
|
| December 1, 2014 |
Exhibit 99.1 IMRIS completes SYMBIS Surgical System human factors study 18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable MINNEAPOLIS, MN, Dec. 1, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the Company has successfully completed the human factors study for the SYMBIS® Surgical System |
|
| December 1, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| November 18, 2014 |
IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Exhibit 99.1 IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum MINNEAPOLIS, Nov. 17, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum at the Westin Grand Central, New York at 8:40 a.m. Eastern Time on Thursday, November 20, 2014. The slides of Mr. Miller's presentat |
|
| November 18, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| October 30, 2014 |
IMRIS INC. $30,000,000 Common Shares Warrants Units Filed Pursuant to Rule 424(b)(3); File No. 333-199241 IMRIS INC. $30,000,000 Common Shares Warrants Units IMRIS Inc. may offer and sell from time to time up to an aggregate of $30,000,000 of common shares (issued separately or upon exercise of warrants), warrants and units comprising any combination of common shares and warrants. The specific terms of any securities offered will be described in su |
|
| October 28, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.4 5 v392295ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Jay D. Miller, President and Chief Executive Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended September 30, 2014. |
|
| October 28, 2014 |
CONSOLIDATED FINANCIAL STATEMENTS September 30, 2014 Exhibit 99.2 CONSOLIDATED FINANCIAL STATEMENTS September 30, 2014 IMRIS Inc. 100-1370 Sony Place Winnipeg, Manitoba T. 763.203.6300 Canada R3T 1N5 F. 204.480.7071 www.imris.com IMRIS INC. Consolidated Balance Sheets Expressed in U.S. $000’s except share and per share data and except as otherwise indicated (Unaudited) September 30, 2014 December 31, 2013 Assets Current assets Cash $ 3,842 $ 6,382 R |
|
| October 28, 2014 |
IMRIS Reports Third-Quarter 2014 Financial Results EX-99.1 2 v392295ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 IMRIS Reports Third-Quarter 2014 Financial Results · New order bookings of $6.1 million in third quarter resulted in ending backlog of $127.2 million; · Order bookings totaled $46.7 million year-to-date 2014 compared with $33 million for entire 2013 year; · Quarterly revenues of $6.9 million were at high end of IMRIS’ expectations; · Company ma |
|
| October 28, 2014 |
EX-99.3 4 v392295ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 MANAGEMENT’S DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2014 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc.’s consolidated results of operations and financial condition for the three and nine months ended Se |
|
| October 28, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE Exhibit 99.5 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Jeffery Bartels, Director - Finance of IMRIS Inc., certify the following: 7. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended September 30, 2014. 8. No misrepresentations: Based on my knowledge, having e |
|
| October 28, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| October 10, 2014 |
IMRSQ / Imris Inc. F-3 - - FORM F-3 As filed with the Securities and Exchange Commission on October 9, 2014 Registration No. |
|
| September 26, 2014 |
IMRIS Announces Waiver and Amendment Agreement and Repricing of Warrants Exhibit 99.1 IMRIS Announces Waiver and Amendment Agreement and Repricing of Warrants MINNEAPOLIS, Sept. 24, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced it has entered into a Waiver and Amendment Agreement with Deerfield Management Company, L.P. ("Deerfield") with respect to the Facility Agreement dated as of September 16, 2013. Deerfield has agreed t |
|
| September 26, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 25, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 25, 2014 |
Exhibit 99.1 Unique IMRIS hybrid OR enables highly complex deformity correction at Dartmouth-Hitchcock Medical Center VISIUS intraoperative MR and CT imaging solutions used for single procedure MINNEAPOLIS, Sept. 25, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that both VISIUS intraoperative MRI (iMRI) and intraoperative CT (iCT) have been utilized fo |
|
| September 11, 2014 |
IMRIS neurosurgical HFD rocker arm receives FDA clearance Exhibit 99.1 IMRIS neurosurgical HFD rocker arm receives FDA clearance Head fixation device (HFD) accessory provides skull stabilization for more patient head sizes MINNEAPOLIS, Sept. 11, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced a new rocker arm accessory that expands choices for neurosurgeons to select the best fixation suited for patients during |
|
| September 11, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 9, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (A |
|
| September 9, 2014 |
EX-99.1 2 ex991.htm NEWS RELEASE DATED SEPTEMBER 9, 2014 Exhibit 99.1 IMRIS sterile wireless imaging coil and Monteris laser technologies combine for first time inside a VISIUS Surgical Theatre with iMRI Intraoperative neurosurgical platforms offer precision and workflow improvement for ablating brain tumors MINNEAPOLIS, Sept. 9, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Com |
|
| August 29, 2014 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change August 29, 2014 Item 3 News Release News release attached as Schedule “A” was disseminated on August 29, 2014 via Canada NewsWire. Item 4 Summary of Material Change ` IMRIS Inc. announced today that |
|
| August 29, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 29, 2014 |
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency Exhibit 99.2 IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency WINNIPEG AND MINNEAPOLIS, MN, Aug. 29, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter, dated August 25, 2014, from the NASDAQ Stock Market LLC ("Nasdaq") stating that for the previous 30 consecutive business days the bid price of the Company's common stock closed below |
|
| August 28, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 26, 2014 |
Highest level evidence published in Neurosurgery journal indicates better outcomes when using iMRI Exhibit 99.1 Highest level evidence published in Neurosurgery journal indicates better outcomes when using iMRI Interim analysis of triple-blind, parallel-controlled trial proves intraoperative MRI more effective than conventional neurosurgery for certain brain tumors MINNEAPOLIS, Aug. 26, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a recently pu |
|
| August 26, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 21, 2014 |
EX-99.1 2 ex991.htm NEWS RELEASE DATED AUGUST 21, 2014 Exhibit 99.1 IMRIS receives Health Canada licensing for integrating latest generation MR scanners within VISIUS Surgical Theatre Core MRI technology provides most advanced scanners for highest intraoperative image quality and best workflow available WINNIPEG, Aug. 21, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") t |
|
| August 21, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 13, 2014 |
IMRIS intraoperative imaging moving system and coils patents granted in Japan Exhibit 99.1 IMRIS intraoperative imaging moving system and coils patents granted in Japan Unique iMRI technology brings diagnostic quality imaging to neurosurgical patients WINNIPEG, Aug. 13, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the granting of three patents by the Japanese patent office related to key technology currently integrated into its |
|
| August 13, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 7, 2014 |
CONSOLIDATED FINANCIAL STATEMENTS June 30, 2014 EX-99.2 3 ex992.htm Q2 INTERIM FINANCIALS Exhibit 99.2 CONSOLIDATED FINANCIAL STATEMENTS June 30, 2014 IMRIS Inc. 100-1370 Sony Place Winnipeg, Manitoba T. 763.203.6300 Canada R3T 1N5 F. 204.480.7071 www.imris.com IMRIS INC. Consolidated Balance Sheets Expressed in U.S. $000’s except share and per share data and except as otherwise indicated (Unaudited) June 30, 2014 December 31, 2013 Assets Curre |
|
| August 7, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE Exhibit 99.5 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Kelly McNeill, Executive Vice President Finance and Administration and Chief Financial Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended June 30, 2014. 2. |
|
| August 7, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 7, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Jay D. Miller, President and Chief Executive Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended June 30, 2014. 2. No misrepresentations: Based on my knowled |
|
| August 7, 2014 |
IMRIS Reports Second-Quarter 2014 Financial Results EX-99.1 2 ex991.htm PRESS RELEASE DATED AUGUST 7, 2014 Exhibit 99.1 IMRIS Reports Second-Quarter 2014 Financial Results · New order bookings of $22.6 million in second quarter; · Order bookings of $40.5 million in first half of 2014 compared with $33 million for the entire 12-month period of 2013; · Four VISIUS Surgical Theatres booked in the second quarter across the globe; · Backlog increases 26 |
|
| August 7, 2014 |
Exhibit 99.3 MANAGEMENT’S DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2014 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc.’s consolidated results of operations and financial condition for the three and six months ended June 30, 2014. In this MD&A, “IMRIS”, the “Company |
|
| July 23, 2014 |
IMRSQ / Imris Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| July 23, 2014 |
Exhibit 99.1 IMRIS receives CE mark for integrating latest generation MR scanners within VISIUS Surgical Theatre in European market Core MRI technology provides most advanced scanners for highest intraoperative image quality and best workflow available MINNEAPOLIS, July 23, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the Company has obtained regu |
|
| June 4, 2014 |
Largest published study shows pituitary tumor removal improved by iMRI and endoscopy together Exhibit 99.1 Largest published study shows pituitary tumor removal improved by iMRI and endoscopy together IMRIS VISIUS intraoperative MRI use enhances patient outcomes MINNEAPOLIS, June 4, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a published retrospective study indicates that use of VISIUS intraoperative MRI (iMRI) combined with endoscopy for |
|
| June 4, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| May 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report For the month of May 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive offices) Check the appropriate box to indicate the rule pursuant to which this form |
|
| May 30, 2014 |
Exhibit 1.02 Conflict Minerals Report of IMRIS Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of IMRIS Inc. (“IMRIS”) for calendar year 2013 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 for definitio |
|
| May 28, 2014 |
SYMBIS Surgical System named to 2014 Space Technology Hall of Fame Exhibit 99.1 SYMBIS Surgical System named to 2014 Space Technology Hall of Fame MRI-compatible robot leveraged from space program technology inspired by goal to improve neurosurgical precision and outcomes MINNEAPOLIS, May 28, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the SYMBIS Surgical System - the second generation of the neuroArm® / SYMBIS™ |
|
| May 28, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 20, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 20, 2014 |
Barnes Jewish Hospital neurosurgeons treat 1000th patient using VISIUS iMRI EX-99.1 2 ex991.htm NEWS RELEASE DATED MAY 20, 2014 Exhibit 99.1 Barnes Jewish Hospital neurosurgeons treat 1000th patient using VISIUS iMRI Ceiling-mounted high-field intraoperative MRI provides improved results and patient outcomes MINNEAPOLIS, May 20, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Barnes-Jewish Hospital in St. Louis is the first |
|
| May 14, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 14, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Jay D. Miller, President and Chief Executive Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended March 31, 2014. 2. No misrepresentations: Based on my knowledge, having e |
|
| May 14, 2014 |
IMRIS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS IMRIS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS · First quarter new order bookings of $18. |
|
| May 14, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 14, 2014 |
CONSOLIDATED FINANCIAL STATEMENTS March 31, 2014 CONSOLIDATED FINANCIAL STATEMENTS March 31, 2014 IMRIS Inc. 100-1370 Sony Place Winnipeg, Manitoba T. 763-203-6300 Canada R3T 1N5 F. 204.480.7071 www.imris.com IMRIS INC. Consolidated Balance Sheets Expressed in U.S. $000’s except share and per share data and except as otherwise indicated (Unaudited) March 31, 2014 December 31, 2013 Assets Current assets Cash $ 7,225 $ 6,382 Restricted cash (note |
|
| May 14, 2014 |
IMRIS reports shareholder vote results at annual meeting Exhibit 99.1 IMRIS reports shareholder vote results at annual meeting WINNIPEG, May 14, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) has announced results of the shareholder vote at its 2014 annual general meeting held May 13, 2014 in Toronto. The Company reported that a substantial majority of the shareholders approved the following management proposals: · Director nominees H. David Graves, St |
|
| May 14, 2014 |
MANAGEMENT’S DISCUSSION AND ANALYSIS For the three months ended March 31, 2014 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc. |
|
| May 14, 2014 |
EX-99.2 3 ex992.htm VOTING RESULTS Exhibit 99.2 REPORT OF VOTING RESULTS PURSUANT TO SECTION 11.3 OF NATIONAL INSTRUMENT 51-102 CONTINUOUS DISCLOSURE OBLIGATIONS The following sets out the matters that were voted upon at the annual meeting of shareholders of IMRIS Inc. (the “Company”) held on May 13, 2014, and the outcome of each vote. Each of the matters set out below is described in greater deta |
|
| May 14, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Kelly McNeill, Executive Vice President Finance and Administration and Chief Financial Officer of IMRIS Inc. |
|
| April 24, 2014 |
Tampa General Hospital launches advanced intraoperative MRI use with first cases Exhibit 99.1 Tampa General Hospital launches advanced intraoperative MRI use with first cases IMRIS VISIUS iMRI improves surgical results and patient outcomes for neurosurgery MINNEAPOLIS, April 24, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a University of South Florida neurosurgical team at Tampa General Hospital (TGH) completed initial cases |
|
| April 24, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| April 17, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| April 17, 2014 |
Neurosurgery journal published study reinforces value of high-field iMRI Exhibit 99.1 Neurosurgery journal published study reinforces value of high-field iMRI VISIUS intraoperative MRI significantly enhances amount of complete resection in brain tumors and leads to better patient outcomes MINNEAPOLIS, April 17, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a study published this month in the journal Neurosurgery by the |
|
| April 8, 2014 |
Current Report of Foreign Issuer - REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF APRIL 2014 Filed by e3 Filing, Computershare 1-800-973-3274 - Imris Inc. - Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Pl |
|
| April 8, 2014 |
IMRIS INC. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 13, 2014 Exhibit 99.1 Exhibit 99.1 IMRIS INC. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 13, 2014 NOTICE IS HEREBY GIVEN THAT the annual meeting of the shareholders of IMRIS Inc. (the “Corporation”) will be held on Tuesday, May 13, 2014 at 6:00 p.m. (EST) at the Grand Hotel Toronto, 225 Jarvis Street, Toronto, Ontario M5B 2C1 (the “Meeting”), for the following purposes: 1. to receive the fi |
|
| April 8, 2014 |
Proxies submitted must be received by 6:00 pm, Eastern Time, on May 9, 2014. Exhibit 99.3 Exhibit 99.3 8th Floor, 100 University Avenue Toronto, Ontario M5J 2Y1 www.computershare.com Security Class Holder Account Number Form of Proxy - Annual General Meeting to be held on May 13, 2014, at 6:00 p.m. Eastern Time This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice |
|
| April 8, 2014 |
IMRIS INC. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 13, 2014 Exhibit 99.2 Exhibit 99.2 IMRIS INC. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 13, 2014 NOTICE IS HEREBY GIVEN THAT the annual meeting of the shareholders of IMRIS Inc. (the “Corporation”) will be held on Tuesday, May 13, 2014 at 6:00 p.m. (EST) at the Grand Hotel Toronto, 225 Jarvis Street, Toronto, Ontario M5B 2C1 (the “Meeting”), for the following purposes: 1. to receive the fi |
|
| April 3, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| April 3, 2014 |
Exhibit 99.1 IMRIS iMRI and ClearPoint Neuro Intervention System utilized for first pediatric laser ablation neurosurgery at Cook Children's Medical Center Latest joint application of these two technologies provides direct, intraoperative visualization during surgery to treat a childhood brain tumor MINNEAPOLIS, MN and IRVINE, CA, April 3, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS") |
|
| April 1, 2014 |
Solutions provide on-demand access to state-of-the-art imaging during procedures Exhibit 99.1 IMRIS sponsoring Practical Clinic and exhibiting intraoperative MR and CT imaging techniques at AANS Solutions provide on-demand access to state-of-the-art imaging during procedures MINNEAPOLIS, April 1, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced sponsorship of a Practical Clinic on brain mapping and awake surgical mapping techniques and |
|
| April 1, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 26, 2014 |
IMRIS pediatric horseshoe headrest enables iMRI for even the youngest neurosurgery patients Exhibit 99.1 IMRIS pediatric horseshoe headrest enables iMRI for even the youngest neurosurgery patients Le Bonheur neurosurgeons complete first cases using MR-safe headrest designed specifically for intraoperative imaging in VISIUS Surgical Theatre MINNEAPOLIS, March 26, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced the initial uses of its neurosurgic |
|
| March 26, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 21, 2014 |
Exhibit 99.1 Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures in Center for Surgical Innovation VISIUS iMRI and iCT expected to expand surgical vision and precision and further research MINNEAPOLIS, March 19, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons at Dart |
|
| March 21, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 5, 2014 |
IMRIS reports 2013 fourth quarter and full-year financial results Exhibit 99.1 IMRIS reports 2013 fourth quarter and full-year financial results · Company completes transition year and lays foundation for profitable growth; · Quarterly revenues of $10.0 million declined primarily due to the timing of shipments; · Net loss in the fourth quarter was $21.6 million, or $0.42 per diluted share, including R&D charges and one-time relocation expenses; · Fourth quarter |
|
| March 5, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 4, 2014 |
CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 EX-99.5 6 v367489ex99-5.htm EXHIBIT 99.5 Exhibit 99.5 CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, Kelly McNeill, certify that: 1. I have reviewed this annual report on Form 40-F of IMRIS Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements |
|
| March 4, 2014 |
CONSOLIDATED FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL STATEMENTS December 31, 2013 IMRIS Inc. 100-1370 Sony Place Winnipeg, Manitoba T. 763-203-6300 Canada R3T 1N5 F. 204.480.7071 www.imris.com REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Shareholders of IMRIS Inc.: We have audited the accompanying consolidated balance sheet of IMRIS Inc. and subsidiaries (the "Company") as of December 3 |
|
| March 4, 2014 |
Exhibit 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IMRIS Inc. (the "Company") on Form 40-F for the fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kelly McNeill, Chief Financial Officer of the Compan |
|
| March 4, 2014 |
CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 99.4 CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, Jay D. Miller, certify that: 1. I have reviewed this annual report on Form 40-F of IMRIS Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under |
|
| March 4, 2014 |
MANAGEMENT’S DISCUSSION AND ANALYSIS For the year ended December 31, 2013 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc. |
|
| March 4, 2014 |
IMRIS Inc. Annual Information Form For the Year Ended December 31, 2013 MARCH 4, 2014 1 TABLE OF CONTENTS TABLE OF CONTENTS 2 FORWARD-LOOKING AND OTHER STATEMENTS 3 GENERAL MATTERS 5 1. CORPORATE STRUCTURE 7 2. GENERAL DEVELOPMENT OF THE BUSINESS 8 3. NARRATIVE DESCRIPTION OF THE BUSINESS 9 4. DIVIDENDS 38 5. CAPITAL STRUCTURE 38 6. MARKET FOR SECURITIES 39 7. DIRECTORS AND OFFICERS 40 8. LEGAL PR |
|
| March 4, 2014 |
Consent of Independent Registered Public Accounting Firm Exhibit 99.9 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in Registration Statement No. 333-183820 on Form F-10 and to the use of our report dated March 5, 2013 relating to the consolidated financial statements of IMRIS Inc. (the “Company”) appearing in this Annual Report on Form 40-F of the Company for the year ended December 31, 2013. /s/ |
|
| March 4, 2014 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IMRIS Inc. (the "Company") on Form 40-F for the fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jay D. Miller, Chief Executive Officer of the Compan |
|
| March 4, 2014 |
Consent of Independent Registered Public Accounting Firm Exhibit 99.8 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in Registration Statement No. 333-183820 on Form F-10 and to the use of our reports dated March 4, 2014, relating to the consolidated financial statements of IMRIS Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting a |
|
| March 4, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F (Check One) ¨ Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2013 Commission file number 1-34975 IMRIS INC. (Exact name of registrant as specified in its cha |
|
| February 26, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| February 26, 2014 |
IMRIS receives Australian regulatory clearance for intraoperative CT solution Exhibit 99.1 IMRIS receives Australian regulatory clearance for intraoperative CT solution VISIUS iCT listing expands availability of state-of-the-art imaging with low dose management accessed effortlessly in the OR MINNEAPOLIS, MN, Feb. 26, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that it has obtained Therapeutic Goods Administration (TGA) regulat |
|
| February 19, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| February 19, 2014 |
IMRIS launches world's first MR-safe and CT-compatible neurosurgical horseshoe headrest Exhibit 99.1 IMRIS launches world's first MR-safe and CT-compatible neurosurgical horseshoe headrest Provides non-rigid head positioning for pediatric and adult patients during brain surgery and intraoperative imaging in the VISIUS Surgical Theatre MINNEAPOLIS, Feb. 19, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the initial launch of the world's firs |
|
| February 14, 2014 |
IMRSQ / Imris Inc. / Flynn James E Passive Investment SC 13G/A 1 e611852sc13ga-imris.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) * IMRIS Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 45322N105 (CUSIP Number) December 31, 2013 (Date |
|
| February 13, 2014 |
IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre Exhibit 99.1 IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre Most advanced Siemens MR scanners provide highest intraoperative image quality and best workflow available MINNEAPOLIS, Feb. 13, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced US Food and Drug Administration clearance of the newest generation VISIUS® Surgical Theatre wh |
|
| February 13, 2014 |
FORM 51-102F3 Material Change Report Exhibit 99.2 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change February 13, 2014 Item 3 News Release News release attached as Schedule “A” was disseminated on February 13, 2014 via Canada NewsWire. Item 4 Summary of Material Change On February 13, 2014, the Com |
|
| February 13, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| February 6, 2014 |
IMRSQ / Imris Inc. / Whitecastle Investments Ltd - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) IMRIS INC. (Name of Issuer) COMMON SHARES (Title of Class of Securities) 45322N105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| January 30, 2014 |
IMRSQ / Imris Inc. / Graves H. David - FORM SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Amendment 3) UNDER THE SECURITIES EXCHANGE ACT OF 19341 IMRIS Inc. |
|
| January 9, 2014 |
IMRSQ / Imris Inc. / 1832 Asset Management L.P. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Year End Filing)* IMRIS INC. (Name of Issuer) COMMON SHARES (Title of Class of Securities) 45322N105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| January 8, 2014 |
Nearly 13,000 patients have benefited from IMRIS VISIUS iMRI EX-99.1 2 ex991.htm NEWS RELEASE DATED JANUARY 8, 2014 Exhibit 99.1 Nearly 13,000 patients have benefited from IMRIS VISIUS iMRI 2014 procedures expected to increase 31% over 8-year total as intraoperative MRI utilization expands to improve outcomes in growing number of neurosurgical applications MINNEAPOLIS, Jan. 8, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today |
|
| January 8, 2014 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2014 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| December 17, 2013 |
Filed pursuant to General Instruction II. L. of Form F-10; File No. 333-183820 No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This Prospectus Supplement, together with the accompanying amended and restated short form base shelf prospectus dated October 16, 2013 to which it relates, as amended or supplemented, constitutes |
|
| December 3, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| December 3, 2013 |
EX-99.1 2 ex991.htm NEWS RELEASE DATED DECEMBER 3, 2013 Exhibit 99.1 MRI Interventions & IMRIS technologies combine to lessen anxiety of DBS surgery on pediatric patients at Cook Children's Medical Center Patients can sleep during deep brain stimulation procedure using intraoperative tools IRVINE, CA, and MINNEAPOLIS, MN, Dec. 3, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS") and MRI In |
|
| November 13, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change November 13, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on November 13, 2013 via Canada NewsWire. Item 4 Summary of Material Change On November 13, 2013, the Com |
|
| November 13, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| November 5, 2013 |
IMRIS REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS IMRIS REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS · Quarterly revenues were $17.8 million, an increase of 54 percent over the prior year; · Net loss in the third quarter improved to $3.8 million, or $0.07 per diluted share, compared with a prior-year net loss of $8.5 million, or $0.19 per diluted share; · Quarterly gross margins of 38.2 percent of sales, a 14.4 percent of sales improvement from t |
|
| November 5, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executiv |
|
| November 5, 2013 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.5 6 v359240ex99-5.htm EXHIBIT 99.5 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Kelly McNeill, Executive Vice President Finance and Administration and Chief Financial Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim per |
|
| November 5, 2013 |
MANAGEMENT’S DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2013 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc. |
|
| November 5, 2013 |
CONSOLIDATED FINANCIAL STATEMENTS September 30, 2013 CONSOLIDATED FINANCIAL STATEMENTS September 30, 2013 IMRIS Inc. 100-1370 Sony Place TF. 1.888.304.0114 Winnipeg, Manitoba T. 204.480.7070 Canada R3T 1N5 F. 204.480.7071 www.imris.com IMRIS INC. Consolidated Balance Sheets Expressed in US $000’s except share and per share data, and except as otherwise indicated (Unaudited) September 30, 2013 December 31, 2012 Assets Current assets Cash $ 20,899 $ 1 |
|
| November 5, 2013 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Jay D. Miller, Chief Executive Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended September 30, 2013. 2. No misrepresentations: Based on my knowledge, having exercised r |
|
| October 31, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| October 31, 2013 |
Surgeons perform world's first ever cases using IMRIS intraoperative CT Exhibit 99.1 Surgeons perform world's first ever cases using IMRIS intraoperative CT VISIUS iCT provides on-demand access, state-of-the-art image quality during spinal procedures MINNEAPOLIS, Oct. 31, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the spinal surgery team at Duke University Medical Center in Durham, NC, has completed the first surgical ca |
|
| October 22, 2013 |
Interim analysis of triple-blind, randomized iMRI trial proves better results for glioma patients Exhibit 99.1 Interim analysis of triple-blind, randomized iMRI trial proves better results for glioma patients Fudan University neurosurgeons receive journal award at CNS for high-ranking clinical research using VISIUS Surgical Theatre MINNEAPOLIS, Oct. 22, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons from Huashan Hospital at Fudan U |
|
| October 22, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| October 16, 2013 |
As filed with the Securities and Exchange Commission on October 16, 2013 Registration No. |
|
| October 10, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.4 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change May 30, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on May 30, 2013 via Canada NewsWire. Item 4 Summary of Material Change On May 30, 2013, the Company announced |
|
| October 10, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.2 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change August 13, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on August 15, 2013 via Canada NewsWire. Item 4 Summary of Material Change August 13, 2013, the Company anno |
|
| October 10, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change September 16, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on September 16, 2013 via Canada NewsWire. Item 4 Summary of Material Change On September 16, 2013, the |
|
| October 10, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| October 10, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.5 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change March 18, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on March 18, 2013.. Item 4 Summary of Material Change On March 18, 2013, the Company announced that it had c |
|
| October 10, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.3 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change July 22, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on July 22, 2013 via Canada NewsWire. Item 4 Summary of Material Change On July 22, 2013, the Company announc |
|
| October 9, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| October 9, 2013 |
IMRIS and Siemens Healthcare collaborate to market intraoperative CT scanners Exhibit 99.1 IMRIS and Siemens Healthcare collaborate to market intraoperative CT scanners Siemens technology at the core of VISIUS iCT's state-of-the-art image quality MINNEAPOLIS, Oct. 9, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") and Siemens Healthcare today announced that the companies have strengthened their sales collaboration through a new agreement that posi |
|
| September 24, 2013 |
Washington University Hospital enrolls first patient in iMRI database expansion EX-99.1 2 ex991.htm NEWS RELEASE DATED SEPTEMBER 24, 2013 Exhibit 99.1 Washington University Hospital enrolls first patient in iMRI database expansion Multiple neurosurgical centers to evaluate long-term effectiveness, efficacy, and value of intraoperative MRI for brain tumor surgery MINNEAPOLIS, Sept. 24, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced t |
|
| September 24, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 19, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 19, 2013 |
IMRIS Announces Addition of Dr. Vipul Patel to SYMBIS™ Advisory Board Exhibit 99.1 IMRIS Announces Addition of Dr. Vipul Patel to SYMBIS™ Advisory Board World's most experienced robotic surgeon to consult on neurosurgical robot MINNEAPOLIS, Sept. 19, 2013 /CNW/ - Global intraoperative imaging company IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Vipul Patel, M.D., of Florida Hospital Celebration Health, has joined the SYMBIS™ Sur |
|
| September 19, 2013 |
FORM 51-102F3 Material Change Report FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. |
|
| September 19, 2013 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 v3554096k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 |
|
| September 19, 2013 |
FACILITY AGREEMENT FACILITY AGREEMENT (this “Agreement”), dated as of September 16, 2013, between IMRIS Inc. |
|
| September 19, 2013 |
GUARANTY AND SECURITY AGREEMENT among IMRIS INC. and THE OTHER PARTIES HERETO, as Grantors and Guarantors, and DEERFIELD PRIVATE DESIGN FUND II, L.P., DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P., DEERFIELD SPECIAL SITUATIONS FUND, L.P. and DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P. as Lenders September 16, 2013 GUARANTY AND SECURITY AGREEMENT THIS GUARANTY AND SECURITY AGREEM |
|
| September 19, 2013 |
SECURITY AGREEMENT among IMRIS INC. and DEERFIELD PRIVATE DESIGN FUND II, L.P., DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P., DEERFIELD SPECIAL SITUATIONS FUND, L.P. and DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P. as Lenders September 16, 2013 SECURITY AGREEMENT THIS SECURITY AGREEMENT dated as of September 16, 2013 (this “Agreement”) is entered into among IMRIS INC. a Canadian |
|
| September 19, 2013 |
REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 16, 2013, by and among IMRIS Inc. |
|
| September 19, 2013 |
GUARANTY AND SECURITY AGREEMENT GUARANTY AND SECURITY AGREEMENT THIS GUARANTY AND SECURITY AGREEMENT dated as of September 16, 2013 (this “Agreement”) is entered into between IMRIS, INC. |
|
| September 18, 2013 |
IMRSQ / Imris Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| September 17, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 17, 2013 |
Exhibit 99.1 First IMRIS intraoperative suite in Canada featuring flexibility of MRI and angiography opens at Health Sciences Centre Winnipeg Neurosurgeons can image, treat patients within three-room suite without moving patients WINNIPEG, Sept. 17, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the official opening of the first VISIUS® Surgical Theatre |
|
| September 16, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.2 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change September 16, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on September 16, 2013 via Canada NewsWire. Item 4 Summary of Material Change On September 16, 2013, the |
|
| September 16, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| September 16, 2013 |
IMRIS enters into a secured loan facility for $25 million in financing. Exhibit 99.1 FOR IMMEDIATE RELEASE IMRIS enters into a secured loan facility for $25 million in financing. WINNIPEG, Manitoba, September 16, 2013 – IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the “Company”) today announced it has entered into a secured loan facility agreement (the “Agreement”) with Deerfield Management Company, L.P. (“Deerfield”) for $25 million in financing. Deerfield is a lea |
|
| August 20, 2013 |
Kelly McNeill - NEWS RELEASE DATED AUGUST 20, 2013 Exhibit 99.1 Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders MINNEAPOLIS, MN and IRVINE, CA, Aug. 20, 2013 /CNW/ - IMRIS Inc. (NASDAQ: |
|
| August 20, 2013 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Addr |
|
| August 15, 2013 |
R. Stephen Armstrong Joins IMRIS Board of Directors Exhibit 99.1 R. Stephen Armstrong Joins IMRIS Board of Directors WINNIPEG, Aug. 15, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the appointment of R. Stephen Armstrong to the Company's Board of Directors effective August 14, 2013. Mr. Armstrong has been Executive Vice President and CFO of Patterson Companies, Inc., since 1999. Patterson is a publicly |
|
| August 15, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 14, 2013 |
CONSOLIDATED FINANCIAL STATEMENTS June 30, 2013 CONSOLIDATED FINANCIAL STATEMENTS June 30, 2013 IMRIS Inc. 100-1370 Sony Place TF. 1.888.304.0114 Winnipeg, Manitoba T. 204.480.7070 Canada R3T 1N5 F. 204.480.7071 www.imris.com IMRIS INC. Consolidated Balance Sheets Expressed in US $000’s except share and per share data, and except as otherwise indicated (Unaudited) June 30, 2013 December 31, 2012 Assets Current assets Cash $ 13,664 $ 19,060 Rest |
|
| August 14, 2013 |
Current Report of Foreign Issuer - REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 14, 2013 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Kelly McNeill, Executive Vice President Finance and Administration and Chief Financial Officer of IMRIS Inc. |
|
| August 14, 2013 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Jay D. Miller, Chief Executive Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended June 30, 2013. 2. No misrepresentations: Based on my knowledge, having exercised reason |
|
| August 14, 2013 |
IMRIS REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS IMRIS REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS · Quarterly revenues of $10.2 million were in line with expectations; · Sold a second VISIUS® Surgical Theatre in Japan and one service contract for a total of $6.2 million resulting in an ending backlog of $111 million; · Received FDA 510K clearance in the U.S. in July 2013 and CE Mark approval in Europe in August 2013 to sell the VISIUS iCT, th |
|
| August 14, 2013 |
MANAGEMENT’S DISCUSSION AND ANALYSIS MANAGEMENT’S DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2013 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc. |
|
| August 8, 2013 |
Cook Children's Medical Center reaches 500th procedure milestone using IMRIS iMRI Exhibit 99.1 Cook Children's Medical Center reaches 500th procedure milestone using IMRIS iMRI Intraoperative MR imaging improves surgical vision, reduces re-operation risk in treating epilepsy, tumors, other neurological disorders MINNEAPOLIS, Aug. 8, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a craniotomy recently performed on a five-year-old |
|
| August 8, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| August 6, 2013 |
IMRIS obtains CE mark for first ceiling-mounted intraoperative CT solution Exhibit 99.1 IMRIS obtains CE mark for first ceiling-mounted intraoperative CT solution VISIUS iCT expands state-of-the-art surgical theater imaging into European market WINNIPEG, MB and MINNEAPOLIS, MN, Aug. 5, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that it has obtained regulatory CE mark for VISIUS® iCT, the first and only ceiling-mounted intr |
|
| August 6, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive |
|
| July 30, 2013 |
Jay D. Miller Appointed Chief Executive Officer Exhibit 99.1 Jay D. Miller Appointed Chief Executive Officer WINNIPEG and MINNEAPOLIS, July 29, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Jay D. Miller, the company's current President and COO, will also become the CEO of IMRIS Inc., effective August 1, 2013. Chairman and CEO David Graves will continue as the Chair of the Board of Directors of |
|
| July 30, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 - 1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change July 29, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on July 29, 2013 via Canada NewsWire. Item 4 Summary of Material Change Effective August 1, 2013, Jay D. Mill |
|
| July 30, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| July 30, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| July 22, 2013 |
IMRIS receives FDA 510K clearance for first ceiling-mounted intraoperative CT solution Exhibit 99.1 IMRIS receives FDA 510K clearance for first ceiling-mounted intraoperative CT solution VISIUS iCT establishes level of intraoperative imaging previously unavailable to surgeons WINNIPEG, July 22, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced US Food and Drug Administration (FDA) 510K clearance to market VISIUS® iCT, the first and only ceili |
|
| July 22, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| June 26, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| June 26, 2013 |
Exhibit 99.1 Le Bonheur Children's Hospital credits VISIUS® iMRI with reducing brain tumor re-surgery rates 2 years post adoption Neurosurgeons say VISIUS® is safe, more precise tool for intraoperative imaging MINNEAPOLIS, June 26, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported that Le Bonheur Children's Hospital in Memphis, TN, is crediting intraoperativ |
|
| June 19, 2013 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Addres |
|
| June 19, 2013 |
Exhibit 99.1 Yale-New Haven neurosurgeons verifying effective eye tumor drug delivery localization with iMRI in VISIUS® Surgical Theatre Intraoperative MRI and angiography confirms retinoblastoma chemotherapy treatment MINNEAPOLIS, MN, June 19, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Yale-New Haven Hospital, New Haven, CT, neurosurgeons are c |
|
| June 12, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive of |
|
| June 12, 2013 |
Tübingen Hospital experience with intraoperative MRI improves patient outcomes Exhibit 99.1 Tübingen Hospital experience with intraoperative MRI improves patient outcomes VISIUS® Surgical Theatre iMRI brings increased tumor resection and limits patient risks MINNEAPOLIS, MN, June 12, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that University Hospital Tübingen neurosurgeons in Tübingen, Germany, are reporting success toward thei |
|
| May 31, 2013 |
James B. Hickey, Jr. Joins IMRIS Board of Directors Exhibit 99.1 James B. Hickey, Jr. Joins IMRIS Board of Directors WINNIPEG, MB, May 30, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the appointment of James Hickey to the company's board of directors effective June 1, 2013. Mr. Hickey is an experienced medical device industry executive who brings more than 25 years of experience in building, managing a |
|
| May 31, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 31, 2013 |
FORM 51-102F3 Material Change Report Exhibit 99.1 FORM 51-102F3 Material Change Report Item 1 Name and Address of Company IMRIS Inc. (the “ Company ”) 100 -1370 Sony Place Winnipeg, Manitoba Canada, R3T 1N5 Item 2 Date of Material Change May 30, 2013 Item 3 News Release News release attached as Schedule “A” was disseminated on May 30, 2013 via Canada NewsWire. Item 4 Summary of Material Change On May 30, 2013, the Company announced t |
|
| May 31, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 30, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 30, 2013 |
EX-99.1 2 ex991.htm PRESS RELEASE DATED MAY 30, 2013 Exhibit 99.1 Advancing Neuroscience: MRI Interventions, IMRIS and Tocagen Combine Technologies to Precisely Deliver Potential Cancer-Fighting Drug to Brain Tumors First Combination of ClearPoint® Neuro Intervention System within VISIUS® Surgical Theatre to Achieve Real-Time MRI-Guided Delivery of Investigational Gene Therapy Drug Toca 511 Highli |
|
| May 22, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 22, 2013 |
IMRIS Announces US Patent for Microsurgical Robot Concept Exhibit 99.1 IMRIS Announces US Patent for Microsurgical Robot Concept Key patent includes claims on haptics, MR compatibility and image-guidance WINNIPEG, May 22, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the allowance of a US patent defining the foundational technologies for its SYMBIS™ Surgical System - a minimally invasive and MRI-compatible mic |
|
| May 6, 2013 |
Exhibit 99.1 |
|
| May 6, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 3, 2013 |
CONSOLIDATED FINANCIAL STATEMENTS March 31, 2013 CONSOLIDATED FINANCIAL STATEMENTS March 31, 2013 IMRIS Inc. 100-1370 Sony Place TF. 1.888.304.0114 Winnipeg, Manitoba T. 204.480.7070 Canada R3T 1N5 F. 204.480.7071 www.imris.com IMRIS INC. Consolidated Balance Sheets Expressed in US $000’s except share and per share data, and except as otherwise indicated (Unaudited) March 31, 2013 December 31, 2012 Assets Current assets Cash $ 27,089 $ 19,060 Re |
|
| May 3, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive off |
|
| May 3, 2013 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Kelly McNeill, Executive Vice President Finance and Administration and Chief Financial Officer of IMRIS Inc. |
|
| May 3, 2013 |
IMRIS REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS FOR IMMEDIATE RELEASE IMRIS REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS WINNIPEG, Manitoba, May 2, 2013 - IMRIS Inc. |
|
| May 3, 2013 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, H. David Graves, Chief Executive Officer of IMRIS Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the "interim filings") of IMRIS Inc. (the "issuer") for the interim period ended March 31, 2013. 2. No misrepresentations: Based on my knowledge, having exercised rea |
|
| May 3, 2013 |
MANAGEMENT’S DISCUSSION AND ANALYSIS For the three months ended March 31, 2013 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc. |
|
| May 1, 2013 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 imris6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address |
|
| May 1, 2013 |
IMRIS establishes SYMBIS™ Surgical System Advisory Board Exhibit 99.1 IMRIS establishes SYMBIS™ Surgical System Advisory Board Three internationally prominent surgeons to consult on neurosurgical robot commercialization WINNIPEG, May 1, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the establishment of the SYMBIS™ Surgical System Advisory Board, comprised of three internationally recognized surgeons in the fi |
|
| April 22, 2013 |
Learn more about IMRIS neurosurgical imaging products at booth #2013 Exhibit 99.1 FOR IMMEDIATE RELEASE IMRIS to exhibit novel state-of-the-art VISIUS® iCT imaging solution at AANS Learn more about IMRIS neurosurgical imaging products at booth #2013 WINNIPEG, Manitoba, April 22, 2013 – IMRIS, Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the “Company”) today announced that it will exhibit its novel intraoperative CT solution with state-of-the-art imaging that is current |
|
| April 22, 2013 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 22, 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executi |
|
| March 25, 2013 |
EX-99.3 4 v339049ex99-3.htm EXHIBIT 99.3 |
|
| March 25, 2013 |
IMRIS Inc. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 2, 2013 Exhibit 99.1 IMRIS Inc. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 2, 2013 NOTICE IS HEREBY GIVEN THAT the annual and special meeting of the shareholders of IMRIS Inc. (the “Corporation”) will be held on Thursday, May 2, 2013 at 6.00 p.m. (EST) at the Park Hyatt Toronto, 4 Avenue Road, Toronto, Ontario M5R 2E8 (the “Meeting”), for the following purposes: 1. to receive t |
|
| March 25, 2013 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 25, 2013 |
IMRIS Inc. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 2, 2013 Exhibit 99.2 IMRIS Inc. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 2, 2013 NOTICE IS HEREBY GIVEN THAT the annual and special meeting of the shareholders of IMRIS Inc. (the “Corporation”) will be held on Thursday, May 2, 2013 at 6.00 p.m. (EST) at the Park Hyatt Toronto, 4 Avenue Road, Toronto, Ontario M5R 2E8 (the “Meeting”), for the following purposes: 1. to receive t |
|
| March 18, 2013 |
Current Report of Foreign Issuer - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 18, 2013 |
IMRIS Inc. Closes Public Offering of Common Shares EX-99.1 2 ex991.htm NEW RELEASE, DATED MARCH 18, 2013 EXHIBIT 99.1 FOR IMMEDIATE RELEASE IMRIS Inc. Closes Public Offering of Common Shares WINNIPEG, Manitoba, March 18, 2013 - IMRIS Inc. (“IMRIS” or the “Company”) (NASDAQ: IMRS; TSX: IM) today announced that it has closed its underwritten public offering of 5,750,000 common shares at a public offering price of US$3.50 per share. The gross proceed |
|
| March 13, 2013 |
Current Report of Foreign Issuer - CURRENT REPORT 6-K 1 v3379736k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N |
|
| March 13, 2013 |
IMRIS Inc. Prices $20.1 Million Public Offering of Common Shares FOR IMMEDIATE RELEASE IMRIS Inc. Prices $20.1 Million Public Offering of Common Shares WINNIPEG, Manitoba, March 13, 2013 - IMRIS Inc. (“IMRIS” or the “Company”) (NASDAQ: IMRS; TSX: IM) today announced that it has priced its previously announced underwritten public offering of 5,750,000 common shares at a public offering price of US$3.50 per share. The gross proceeds to IMRIS, before underwriting |
|
| March 13, 2013 |
Current Report of Foreign Issuer - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 13, 2013 |
Filed pursuant to General Instruction II.L. of Form F-10; File No. 333-183820 5,750,000 shares IMRIS INC. Common Shares We are offering 5,750,000 of our common shares, which we refer to as the “Common Shares,” at a price of US$3.50 per common share. We refer to the offering of the Common Shares as the “Offering”. Our outstanding common shares are listed and posted for trading on the Toronto Stock |
|
| March 13, 2013 |
UNDERWRITING AGREEMENT March 13, 2013 IMRIS Inc. 100-1370 Sony Place Winnipeg, Manitoba R3T 1N5 Attention: Mr. H. David Graves Chairman and Chief Executive Officer Dear Sir: Canaccord Genuity Corp. and Canaccord Genuity Inc. (the “Lead Underwriters”) and Cowen and Company, LLC (together with the Lead Underwriters, the “Underwriters” and each individually, an “Underwriter”) understand that, subject |
|
| March 13, 2013 |
IMRIS Inc. Announces Proposed Public Offering of Common Shares FOR IMMEDIATE RELEASE IMRIS Inc. Announces Proposed Public Offering of Common Shares WINNIPEG, Manitoba, March 12, 2013 - IMRIS Inc. (“IMRIS” or the “Company”) (NASDAQ: IMRS; TSX: IM) today announced that it has commenced an underwritten public offering of its common shares. The offering is being conducted in the United States pursuant to the Company’s effective shelf registration statement filed |
|
| March 12, 2013 |
Filed pursuant to General Instruction II.L. of Form F-10; File No. 333-183820 Subject to Completion, dated March 12, 2013 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell securities, nor are they soliciting an offer to buy securities, in any jurisdiction wher |
|
| March 12, 2013 |
CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 99.4 CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, H. David Graves, certify that: 1. I have reviewed this annual report on Form 40-F of IMRIS Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances und |
|
| March 12, 2013 |
Exhibit 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IMRIS Inc. (the "Company") on Form 40-F for the fiscal year ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kelly McNeill, Chief Financial Officer of the Compan |
|
| March 12, 2013 |
Exhibit 99.1 NOTE TO READER: This corrected Annual Information Form has been filed by IMRIS Inc. (“IMRIS”) for the purpose of correcting the following of the Annual Information Form dated March 5, 2012 (the “IMRIS AIF”): ● in Section 2.1 (“Fiscal 2012”), the number of systems sold as at December 31, 2012 was 58 and not 59. Similarly, IMRIS had sold seven systems in Canada and not eight; ● in Secti |
|
| March 12, 2013 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IMRIS Inc. (the "Company") on Form 40-F for the fiscal year ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, H. David Graves, Chief Executive Officer of the Comp |
|
| March 12, 2013 |
Exhibit 99.2 NOTE TO READER: This corrected Management’s Discussion and Analysis has been filed by IMRIS Inc. (“IMRIS”) for the purpose of correcting the following of the Management’s Discussion and Analysis dated March 5, 2012 (the “IMRIS MDA”): ● in the Annual Results of Operations chart on page 9 of the IMRIS MDA, under “basic and diluted loss per share”, the amount was corrected to show (.47) |
|
| March 12, 2013 |
CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 99.5 CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, Kelly McNeill, certify that: 1. I have reviewed this annual report on Form 40-F of IMRIS Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under |
|
| March 12, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F/A (Amendment No. 1) (Check One) ¨ Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2012 Commission file number 1-34975 IMRIS INC. (Exact name of registrant as |
|
| March 6, 2013 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IMRIS Inc. (the "Company") on Form 40-F for the fiscal year ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, H. David Graves, Chief Executive Officer of the Comp |
|
| March 6, 2013 |
Consent of Independent Registered Chartered Accountants Exhibit 99.8 Consent of Independent Registered Chartered Accountants We consent to the incorporation by reference in Registration Statement No. 333-183820 on Form F-10 and to the use of our reports dated March 5, 2013 relating to the consolidated financial statements of IMRIS Inc. (the “Company”) and the effectiveness of the Company’s internal control over financial reporting appearing in this Ann |
|
| March 6, 2013 |
CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 99.5 CERTIFICATION PURSUANT TO RULE 13a-14 OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, Kelly McNeill, certify that: 1. I have reviewed this annual report on Form 40-F of IMRIS Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under |
|
| March 6, 2013 |
Current Report of Foreign Issuer - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2013 Commission File Number: 001-34975 IMRIS INC. (Translation of registrant's name into English) 100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5 (Address of principal executive o |
|
| March 6, 2013 |
Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS For the year ended December 31, 2012 Tables are expressed in USD $000’s except share and per share amounts The following provides management’s discussion and analysis (‘‘MD&A’’) of IMRIS Inc.’s consolidated results of operations and financial condition for the year ended December 31, 2012. In this MD&A, “IMRIS”, the “Company”, “we”, “our” and “us” |
|
| March 6, 2013 |
CONSOLIDATED FINANCIAL STATEMENTS December 31, 2012 March 5, 2013 Exhibit 99.3 Audited Consolidated Financial Statements and Notes thereto for the fiscal years ended December 31, 2012 and 2011 CONSOLIDATED FINANCIAL STATEMENTS December 31, 2012 March 5, 2013 IMRIS Inc. 100-1370 Sony Place TF. 1.888.304.0114 Winnipeg, Manitoba T. 204.480.7070 Canada R3T 1N5 F. 204.480.7071 www.imris.com Report of Independent Registered Chartered Accountants To the Board of Direct |
|
| March 6, 2013 |
IMRIS REPORTS FOURTH QUARTER AND ANNUAL 2012 FINANCIAL RESULTS FOR IMMEDIATE RELEASE IMRIS REPORTS FOURTH QUARTER AND ANNUAL 2012 FINANCIAL RESULTS WINNIPEG, Manitoba, March 5, 2013 - IMRIS Inc. |
|
| March 6, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F (Check One) ¨ Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or x Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2012 Commission file number 1-34975 IMRIS INC. (Exact name of registrant as specified in its cha |
